皮肤癌生活质量影响工具(SCQOLIT)在非黑色素瘤皮肤癌中的可行性研究
这项前瞻性可行性研究在318例新诊断的非黑色素瘤皮肤癌患者中评估SCQOLIT的可行性与心理测量学特性。结果显示SCQOLIT可被患者和皮肤科工作人员接受,基线平均得分5.33,内部一致性Cronbach's α为0.84,且与EQ-5D效度验证一致。
要点
- SCQOLIT在非黑色素瘤皮肤癌门诊中患者和工作人员均可接受。
- SCQOLIT内部一致性Cronbach's α为0.84,效度与EQ-5D一致。
- 基线平均SCQOLIT得分5.33,2.6%患者得分≥20,13.9%得分为0。
核心结论
- SCQOLIT在皮肤科皮肤癌门诊中对患者和工作人员均可接受,其心理测量学特性确认了在非黑色素瘤皮肤癌人群中的效用。
研究设计与样本
- 前瞻性可行性研究,纳入318例经组织学确诊的非黑色素瘤皮肤癌患者,分为低危组和高危组。
- 患者完成SCQOLIT、EQ-5D和过渡条目问卷,低危组在基线和3个月时评估,高危组在基线和3个月及6-9个月时评估。
- 对部分患者进行结构化访谈,并通过工作人员评估表和焦点小组收集临床医生体验。
主要发现
- 基线平均SCQOLIT得分为5.33,2.6%的患者得分≥20,13.9%得分为0,未观察到天花板效应。
- SCQOLIT与EQ-5D的效度验证一致,Cronbach's α为0.84,显示内部一致性。
- 13例接受访谈的患者认为SCQOLIT全面,能捕捉健康相关生活质量影响并帮助向临床医生表达需求。
- 大多数临床医生认为SCQOLIT在促进讨论方面「非常有用」或「在一定程度上有效」。
临床怎么用
- SCQOLIT可用于非黑色素瘤皮肤癌患者的生活质量评估,帮助临床医生了解患者需求并促进沟通。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Incidence of non-melanoma skin cancers (NMSCs) is increasing and can significantly impact on quality of life (QOL), yet there are few studies evaluating patient-reported outcome measures (PROMs) in NMSC populations. We undertook a prospective feasibility study to evaluate a skin cancer-specific PROM, the Skin Cancer Quality of Life Impact Tool (SCQOLIT), in patients with a new diagnosis of NMSC. OBJECTIVES: (i) To establish acceptability of SCQOLIT in dermatology clinics, (ii) a descriptive analysis of SCQOLIT scores in NMSC. METHODS: Patients with histologically confirmed NMSC completed SCQOLIT, EQ-5D and a transition item. Questionnaires were completed at baseline and 3 months for group 1 ('low-risk' NMSC) and group 2 ('high-risk' NMSC) with additional questionnaires at 6-9 months for group 2. Patients participated in structured interviews. Clinician experience was captured through staff evaluation forms and a focus group. Acceptability and psychometric properties of SCQOLIT were assessed. RESULTS: Overall, 318 patients consented to participate. Mean SCQOLIT score at baseline was 5.33, with 2.6% of patients scoring ≥20. No ceiling effects were observed, whilst 13.9% scored 0. Validity was demonstrated against EQ-5D. Cronbach's alpha 0.84 demonstrated internal consistency. Thirteen patients were interviewed and thought SCQOLIT was comprehensive, captured impact on health-related QOL and helped express their needs to clinicians. Most clinicians found SCQOLIT 'very useful' or 'useful to some extent' in facilitating discussions. CONCLUSIONS: This feasibility study demonstrates that SCQOLIT is acceptable to patients and staff in dermatology skin cancer clinics. The psychometric properties of SCQOLIT confirm its utility in NMSC populations.
引用
- Wali GN, Gibbons E, Kelly L, et al. Use of the Skin Cancer Quality of Life Impact Tool (SCQOLIT) - a feasibility study in non-melanoma skin cancer. J Eur Acad Dermatol Venereol. 2019. PMID: 31419362. doi:10.1111/jdv.15887
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。